Bank of America Corporation (BAC) and its subsidiary BofA Finance LLC have announced the offering of Accelerated Return Notes (ARNs) linked to an International Equity Index Basket. The ARNs, with a principal amount of $10 per unit, have a term of approximately 14 months and are linked to a basket of international equity indices including the EURO STOXX 50, FTSE 100, Nikkei Stock Average, Swiss Market Index, S&P/ASX 200, and FTSE China 50 Index. The EURO STOXX 50 Index has been assigned an initial weight of 40%, while the FTSE 100 and Nikkei Stock Average indices each have a 20% weight. The Swiss Market Index and S&P/ASX 200 Index each have a 7.50% weight, and the FTSE China 50 Index has a 5% weight. The ARNs offer a 3-to-1 upside...Show More

Bank of America Corporation (BAC) and its subsidiary BofA Finance LLC have announced the offering of Accelerated Return Notes (ARNs) linked to an International Equity Index Basket. The ARNs, with a principal amount of $10 per unit, have a term of approximately 14 months and are linked to a basket of international equity indices including the EURO STOXX 50, FTSE 100, Nikkei Stock Average, Swiss Market Index, S&P/ASX 200, and FTSE China 50 Index. The EURO STOXX 50 Index has been assigned an initial weight of 40%, while the FTSE 100 and Nikkei Stock Average indices each have a 20% weight. The Swiss Market Index and S&P/ASX 200 Index each have a 7.50% weight, and the FTSE China 50 Index has a 5% weight. The ARNs offer a 3-to-1 upside exposure to increases in the Market Measure, capped at a value between $11.55 to $11.95 per unit, which translates to a 15.50% to 19.50% return over the principal amount. However, investors also face a 1-to-1 downside exposure with 100% of their principal at risk. The notes do not pay interest and are not listed on any exchange. BofA Finance and BAC have highlighted several risk factors, including the potential loss of principal, credit risk of the issuer and guarantor, limited investment return, and market volatility. The final terms will be determined on the pricing date, and investors are advised to read the Preliminary Offering Documents for a full understanding of the product and associated risks.